Clarus Lifesciences II, L.P., 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 207,176 shares at $3.50 ($731K) on 2009-12-18, disclosed to the SEC on 2009-12-18.
Scheduled sale ($731k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.58 | 67,800 | $243K | 33.2% |
| 2 | $3.50 | 129,476 | $453K | 62.0% |
| 3 | $3.50 | 9,900 | $35K | 4.7% |
| Total | $3.53 avg | 207,176 | $731K | 100% |
| Filing → |
| ACHN | SELL | 2009-12-23 | $1.0M | — | Filing → |